BETA: Please send your feedback!

Bristol-Myers Squibb

NYS:BMY

Pharmaceuticals: Major

Market Cap

—

MEGA cap

Share Price↑↓←

(—)

YTD Return ↑↓←

—

since start of 2022

P/E Ratio

—

Corporate Values

5
2
2
—
2
3
5
5
1
—
—
3

Carbon Footprint
Pollution Prevention
Water Conservation
Data & Privacy Protection
Consumer Health, Wellness & Safety
Employee Ownership, Satisfaction, Benefits & Pay
Workplace Health and Safety
Integrity of Corporate Governance
Ethical Practices
Usage of Conflict Materials
Forced Labor
Diversity of Corporate Leadership

About

Pharmaceuticals: MajorFounded 1933

Bristol-Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It includes chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. The company was founded in August 1933 and is headquartered in New York, NY.

Headquarters

345 Park Avenue

New York, NY 10154

Executives

Name	Title	Gender
Sandra Leung	Executive Vice President & General Counsel	Female
John E. Elicker, MBA	Senior VP-Public Affairs & Investor Relations	Male
Thomas James Lynch, Jr., MD	Chief Scientific Officer & Executive VP	Male
Charles A. Bancroft, MBA, CPA	CFO, EVP & Head-Global Business Operations	Male
Paul von Autenried	Chief Information Officer & Senior Vice President	Male
Giovanni Caforio, MD	Chairman & Chief Executive Officer	Male
Ann Powell Judge	Chief Human Resources Officer & Senior VP	Female

Mindful Investing Summary

Carbon Footprint
5N/A
Bristol-Myers Squibb is a top performer among its competitors for its carbon footprint. A company’s performance in this category is based on its success in implementing energy efficiency measures. Investments in energy efficient technology, green building and sourcing of renewable energy can all lead to cost savings and reduce the company’s contribution to climate change.
Pollution Prevention
2N/A
Bristol-Myers Squibb performs poorly on this issue. Companies are evaluated on pollution prevention by the levels of waste (including hazardous waste) they produce and release into the environment, and can be affected by whether they develop products that can reduce exposure to pollution.
Water Conservation
2N/A
Bristol-Myers Squibb performs poorly among its peers in this category. A company’s score in this category depends on its measures to minimize water usage and impacts on stressed or drought-prone water resources.
Data & Privacy Protection
—N/A
Bristol-Myers Squibb among its peers and competitors for data privacy and protection. Companies today digitally manage vast amounts of personal information about their clients. A company’s score on this issue is based on the systems, products and procedures it has in place to minimize the risk for data and privacy breaches.
Consumer Health, Wellness & Safety
2N/A
Bristol-Myers Squibb performs poorly compared to its peers and competitors Companies in this category manage its product and safety risks.
Employee Ownership, Satisfaction, Benefits & Pay
3N/A
Bristol-Myers Squibb is an average performer among its peers for employee satisfaction and pay. A company’s score on this issue depends on its frequency and likelihood of labor disputes as well as its practices to keep and retain talent - such as compensation, family leave, employee health care and other benefits. Employers that are rated as good to work for consistently produce higher stock returns than their peers.
Workplace Health and Safety
5N/A
Bristol-Myers Squibb is a top performer among its competitors on this issue. A company’s workplace health and safety is evaluated not only by the number of accidents and injuries in the workplace, but also by their safety policies, training procedures, and their investment in equipment that can reduce accidents.
Integrity of Corporate Governance
5N/A
Bristol-Myers Squibb is a top performer among its competitors on corporate governance. This score is determined by the company’s accounting practices, executive pay, board organization and ownership structure.
Ethical Practices
1N/A
Bristol-Myers Squibb performs very poorly compared to its peers and competitors. A company’s rating on this issue is based on its history of controversies related to unethical corporate behavior, such as false claims about their products, price fixing, executive misconduct, insider trading or fraudulent practices.
Usage of Conflict Materials
—N/A
Bristol-Myers Squibb among its competitors in this category. Certain products use raw materials that are commonly sourced from militias or other organizations that promote or engage in conflict in their region. To perform well in this category companies must provide adequate assurances that any of these metals used in their production are in fact from conflict-free sources.
Forced Labor
—N/A
Bristol-Myers Squibb compared to its competitors on forced labor. A company’s score on this issue depends on its use of forced labor and on its work conditions for outsourced labor.
Diversity of Corporate Leadership
3N/A
Bristol-Myers Squibb is an average performer based on its peers as well as companies in similar geographic regions. Companies are assessed on factors such as board diversity and senior management diversity. Companies performing well on this issue typically are more profitable than its peers, while companies with very poor scores typically have greater stock price volatility and lower returns on capital.

Bristol-Myers Squibb - Competitors and Related Companies

How Bristol-Myers Squibb stacks up to its peers in thePharmaceuticals: Major industry or with competing business segments.

Bristol-Myers Squibb

NYS:BMY

Pharmaceuticals: Major

Share Price↑↓←

YTD Return ↑↓←

since start of 2022

Corporate Values

5
2
2
—
2
3
5
5
1
—
—
3

Carbon Footprint
Pollution Prevention
Water Conservation
Data & Privacy Protection
Consumer Health, Wellness & Safety
Employee Ownership, Satisfaction, Benefits & Pay
Workplace Health and Safety
Integrity of Corporate Governance
Ethical Practices
Usage of Conflict Materials
Forced Labor
Diversity of Corporate Leadership

Amgen

NAS:AMGN

Biotechnology

Share Price↑↓←

YTD Return ↑↓←

since start of 2022

Corporate Values

5
5
5
—
5
5
1
2
5
—
—
3

Carbon Footprint
Pollution Prevention
Water Conservation
Data & Privacy Protection
Consumer Health, Wellness & Safety
Employee Ownership, Satisfaction, Benefits & Pay
Workplace Health and Safety
Integrity of Corporate Governance
Ethical Practices
Usage of Conflict Materials
Forced Labor
Diversity of Corporate Leadership

Celgene

NAS:CELG

Biotechnology

Share Price↑↓←

YTD Return ↑↓←

since start of 2022

Corporate Values

3
1
3
—
3
5
5
1
5
—
—
4

Carbon Footprint
Pollution Prevention
Water Conservation
Data & Privacy Protection
Consumer Health, Wellness & Safety
Employee Ownership, Satisfaction, Benefits & Pay
Workplace Health and Safety
Integrity of Corporate Governance
Ethical Practices
Usage of Conflict Materials
Forced Labor
Diversity of Corporate Leadership

Eli Lilly

NYS:LLY

Pharmaceuticals: Major

Share Price↑↓←

YTD Return ↑↓←

since start of 2022

Corporate Values

5
2
1
—
3
4
2
1
4
—
—
4

Carbon Footprint
Pollution Prevention
Water Conservation
Data & Privacy Protection
Consumer Health, Wellness & Safety
Employee Ownership, Satisfaction, Benefits & Pay
Workplace Health and Safety
Integrity of Corporate Governance
Ethical Practices
Usage of Conflict Materials
Forced Labor
Diversity of Corporate Leadership

Johnson & Johnson

NYS:JNJ

Pharmaceuticals: Major

Share Price↑↓←

YTD Return ↑↓←

since start of 2022

Corporate Values

5
3
5
—
2
5
5
2
1
—
—
3

Carbon Footprint
Pollution Prevention
Water Conservation
Data & Privacy Protection
Consumer Health, Wellness & Safety
Employee Ownership, Satisfaction, Benefits & Pay
Workplace Health and Safety
Integrity of Corporate Governance
Ethical Practices
Usage of Conflict Materials
Forced Labor
Diversity of Corporate Leadership

Sanofi

PAR:SAN-FR

Pharmaceuticals: Major

Share Price↑↓←

YTD Return ↑↓←

since start of 2022

Corporate Values

5
3
4
—
3
1
5
4
5
—
—
5

Carbon Footprint
Pollution Prevention
Water Conservation
Data & Privacy Protection
Consumer Health, Wellness & Safety
Employee Ownership, Satisfaction, Benefits & Pay
Workplace Health and Safety
Integrity of Corporate Governance
Ethical Practices
Usage of Conflict Materials
Forced Labor
Diversity of Corporate Leadership